These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 3136700

  • 1. [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
    Nishiyama M, Takagami S, Kirihara Y, Saeki T, Niimi K, Kim R, Jinushi K, Toge T, Niimoto M, Hattori T.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2285-90. PubMed ID: 3136700
    [Abstract] [Full Text] [Related]

  • 2. The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.
    Nishiyama M, Takagami S, Kirihara Y, Saeki T, Hirabayashi N, Nosoh Y, Niimoto M, Hattori T.
    Jpn J Surg; 1988 Nov; 18(6):725-8. PubMed ID: 2977626
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
    Yamada Y, Muramatsu T, Honda N, Fukatsu H, Segawa A, Hirata N, Senda H.
    Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experimental studies on subrenal capsule assay using cyclosporin A treated mice--the optimal treatment schedules of CsA and anticancer agents (mitomycin C and 5-fluorouracil)].
    Kusuyama T, Okuyama Y, Fujita M, Taguchi T.
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):259-67. PubMed ID: 2105699
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
    Yanase I, Shirahama T, Kayajima T, Ohi Y.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):709-12. PubMed ID: 3128184
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M, Mäenpää J, Söderström KO, Kangas L, Leppänen M, Cantell K.
    Med Biol; 1983 Apr; 61(5):275-9. PubMed ID: 6200736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
    Anai H, Maehara Y, Kusumoto H, Masuda H, Sugimachi K.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):635-8. PubMed ID: 3103537
    [Abstract] [Full Text] [Related]

  • 15. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y, Yoshida I, Kamoshida S, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [Abstract] [Full Text] [Related]

  • 16. [In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
    Niimi K, Nishiyama M, Hirabayashi N, Yamaguchi M, Nosoh Y, Wang DC, Toge T, Niimoto M, Hattori T.
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1281-5. PubMed ID: 3107479
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
    Okabe H, Toko T, Saito H, Nakano K, Fujioka A, Yuasa C, Takeda S, Unemi N.
    Anticancer Res; 1997 May; 17(1A):157-64. PubMed ID: 9066646
    [Abstract] [Full Text] [Related]

  • 18. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
    Nakashima T, Miyagi M, Kusumoto T.
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [Abstract] [Full Text] [Related]

  • 20. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
    Matsumoto S, Igishi T, Hashimoto K, Kodani M, Shigeoka Y, Nakanishi H, Touge H, Kurai J, Makino H, Takeda K, Yasuda K, Hitsuda Y, Shimizu E.
    Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.